ClinicalTrials.gg
Not yet recruitingNCT07727499Updated Jul 27, 2026

Laparoscopic Appendectomy: Outcomes of 10 mmHg Versus 15 mmHg Intra-abdominal Pressure

An interventional study of Laparoscopic appendectomy with 10 mmHg pneumoperitoneum and Laparoscopic appendectomy with 15 mmHg pneumoperitoneum in Appendectomy, Laparoscopic and Intra Abdominal Pressure, sponsored by Ankara Etlik City Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-07-27.

Sponsored by Ankara Etlik City Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This prospective, randomized controlled trial aims to compare the clinical outcomes of laparoscopic appendectomy performed under two standard pneumoperitoneum pressures (10 mmHg and 15 mmHg). The primary objective is to evaluate postoperative pain, while secondary outcomes include operative time, conversion rate, time to first flatus and bowel movement, length of hospital stay, postoperative ileus, and intra-abdominal abscess formation. The study will determine whether lower-pressure pneumoperitoneum provides comparable surgical conditions while improving postoperative recovery.

Read the detailed description

Laparoscopic appendectomy is the standard surgical treatment for acute appendicitis. Carbon dioxide pneumoperitoneum is essential for adequate visualization and operative exposure; however, the optimal intra-abdominal pressure remains controversial. Standard pneumoperitoneum pressures of 12-15 mmHg provide satisfactory visualization but may contribute to increased postoperative pain and adverse cardiopulmonary effects. Lower-pressure pneumoperitoneum has the potential to reduce postoperative discomfort but may increase technical difficulty during surgery.

This single-center, prospective, randomized controlled trial will be conducted at Ankara Etlik City Hospital. Adult patients undergoing laparoscopic appendectomy for acute appendicitis will be randomly assigned to undergo surgery with either 10 mmHg or 15 mmHg pneumoperitoneum. All other perioperative management and surgical techniques will be standardized.

The primary outcome is postoperative pain assessed using the Numeric Rating Scale (NRS). Secondary outcomes include operative time, conversion to open surgery, time to first flatus, time to first bowel movement, length of hospital stay, postoperative ileus, postoperative intra-abdominal abscess, emergency department readmission, and postoperative complications. Patients will be followed according to the institutional postoperative care protocol, including outpatient follow-up for the assessment of postoperative complications.

The results of this study are expected to provide evidence regarding the optimal pneumoperitoneum pressure during laparoscopic appendectomy by balancing surgical exposure with postoperative recovery and patient safety.

02

Conditions studied

  • Appendectomy, Laparoscopic
  • Intra Abdominal Pressure

Keywords

  • pain
  • vas
  • flatus
  • pressure
  • appendicitis
  • intra-abdominal pressure
03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's planned enrollment of 150 is above the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Ankara Etlik City Hospital is the lead sponsor of 176 studies on the registry; 77 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-60 years.
  • Clinical and/or radiological diagnosis of acute appendicitis.
  • Planned laparoscopic appendectomy(Uncomplicated acute appendicitis considered suitable for laparoscopic management).
  • I-III.
  • Written .

Exclusion criteria

Exclusion Criteria:

  • Age \<18 years and >60 years
  • Pregnancy
  • Appendiceal mass or suspected appendiceal
  • Diffuse peritonitis requiring planned open surgery
  • Severe cardiopulmonary disease in whom pneumoperitoneum pressure cannot be standardized
  • Previous extensive abdominal surgery causing expected severe adhesions
  • Patients requiring additional major abdominal procedure
  • Missing consent
  • Incomplete postoperative follow-up
  • Patients managed non-operatively without surgery
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
150 participants (estimated)

Study arms

  • Active comparator
    10 mmHg Pneumoperitoneum

    Participants assigned to this arm will undergo laparoscopic appendectomy using a pneumoperitoneum pressure of 10 mmHg throughout the procedure. Patients will be allocated using sealed opaque envelope randomization. All other perioperative management and surgical techniques will be standardized.

    Procedure: Laparoscopic appendectomy with 10 mmHg pneumoperitoneum

  • Active comparator
    15 mmHg Pneumoperitoneum

    Participants assigned to this arm will undergo laparoscopic appendectomy using a pneumoperitoneum pressure of 15 mmHg throughout the procedure. Patients will be allocated using sealed opaque envelope randomization. All other perioperative management and surgical techniques will be standardized.

    Procedure: Laparoscopic appendectomy with 15 mmHg pneumoperitoneum

Interventions

  • ProcedureLaparoscopic appendectomy with 10 mmHg pneumoperitoneum

    Laparoscopic appendectomy performed using an intra-abdominal pneumoperitoneum pressure of 10 mmHg.

  • ProcedureLaparoscopic appendectomy with 15 mmHg pneumoperitoneum

    Laparoscopic appendectomy performed using an intra-abdominal pneumoperitoneum pressure of 15 mmHg.

06

What researchers measure

Primary outcomes

  1. Postoperative pain (Numeric Rating Scale [NRS] 0-10)

    Postoperative pain will be assessed using the 11-point Numeric Rating Scale (NRS; 0 = no pain, 10 = worst imaginable pain). Pain scores will be compared between the 10 mmHg and 15 mmHg pneumoperitoneum groups.

    Time frame: At 6 and 24 hours postoperatively

Secondary outcomes

  1. Time to first flatus

    Time from completion of surgery to the first passage of flatus, recorded in hours

    Time frame: From the end of surgery until first passage of flatus, assessed up to hospital discharge (approximately 7 days)

  2. Length of hospital stay

    Duration of hospitalization measured from the end of surgery until hospital discharge

    Time frame: From surgery until hospital discharge (up to 30 days)

  3. Carbon dioxide (CO₂) volume required to achieve target pneumoperitoneum

    The volume of carbon dioxide required to establish the target pneumoperitoneum pressure (10 mmHg or 15 mmHg) at the beginning of laparoscopic appendectomy will be recorded and compared between groups

    Time frame: At the beginning of surgery

  4. Need for conversion to 15 mmHg pneumoperitoneum

    The proportion of participants initially assigned to 10 mmHg pneumoperitoneum who require conversion to 15 mmHg during surgery owing to inadequate operative exposure or technical difficulty.

    Time frame: During surgery

  5. Postoperative ileus

    Incidence of postoperative ileus diagnosed according to clinical findings and need for additional management.

    Time frame: Within 30 days after surgery

  6. Intra-abdominal abscess

    Incidence of postoperative intra-abdominal abscess confirmed clinically and/or radiologically.

    Time frame: Within 30 days after surgery

  7. Surgical site infection

    Incidence of superficial or deep surgical site infection according to CDC criteria

    Time frame: Within 30 days after surgery

  8. Postoperative analgesic consumption

    Total postoperative analgesic requirement during the hospitalization period.

    Time frame: From the end of surgery until 24 hours after surgery.

  9. Surgical difficulty score

    Surgical difficulty assessed immediately after completion of the procedure by the operating surgeon using a 5-point Likert Surgical Difficulty Scale (1 = very easy, 2 = easy, 3 = moderate, 4 = difficult, 5 = very difficult). Scores range from 1 to 5, with higher scores indicating greater surgical difficulty.

    Time frame: Immediately after completion of surgery

  10. Operation time

    Total operative time measured from skin incision to skin closure and compared between the two pneumoperitoneum pressure groups

    Time frame: During surgery

  11. Intraoperative Complications

    Incidence of intraoperative complications, including bleeding, bowel injury, vascular injury, or other procedure-related adverse events occurring during laparoscopic appendectomy

    Time frame: During surgery

  12. Emergency department visit after discharge

    Number of participants requiring an emergency department visit related to postoperative complications after hospital discharge

    Time frame: Within 30 days after surgery

  13. Reoperation

    Number of participants requiring any unplanned surgical reintervention related to postoperative complications

    Time frame: Within 30 days after surgery

  14. postoperative complications

    Postoperative complications occurring within 30 days after surgery will be classified according to the Clavien-Dindo classification

    Time frame: Within 30 days after surgery

  15. Leiden Surgical Rating Scale (LSRS)

    Surgical conditions will be evaluated by the operating surgeon using the Leiden Surgical Rating Scale (LSRS), a validated 5-point scale ranging from 1 (extremely poor conditions) to 5 (optimal surgical conditions)

    Time frame: Immediately after surgery

07

Study locations

1 site
08

References and documents

Publications

  • https://academic.oup.com/gastro/article/doi/10.1093/gastro/goae052/7717317?utm_source=chatgpt.com
  • https://journals.lww.com/njcp/fulltext/2024/06000/low_pressure_versus_standard_pressure.10.aspx?utm_source=chatgpt.com&__cf_chl_f_tk=Eb29rzCFkj3a_dXPqeUg.Gp3YmpTD2NNq9oCDSCAHjo-1783178717-1.0.1.1-uuVgHTnAcUecXo437tA9Setum0rqkaXoaoMcGgklnPQ
  • https://pubmed.ncbi.nlm.nih.gov/20306755/
  • https://pubmed.ncbi.nlm.nih.gov/24503370/
  • https://pubmed.ncbi.nlm.nih.gov/26275545/
  • https://pubmed.ncbi.nlm.nih.gov/32253560/

Related links

Individual participant data

Plan to share: No — I can give IPD on request after submission of paper

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07727499
Responsible party
Dr Yilmaz TURK (Operator Doctor, Ankara Etlik City Hospital) — Principal investigator
First posted
Jul 27, 2026
Start date
Jul 27, 2026 (estimated)
Primary completion
Oct 27, 2026 (estimated)
Completion
Oct 27, 2027 (estimated)
Last update
Jul 27, 2026

Study contacts

Yılmaz Türk, Operator Doctor
Contact
yturk9@gmail.com
+905321349903 ext. +90

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion